Study on AVA Use in Continuous Renal Replacement Therapy to Reduce Catheter Risks
A study will assess the feasibility of using existing arteriovenous access for continuous renal replacement therapy in critically ill patients.
Phase III
Nephrology / Dialysis
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This study could significantly impact clinical practices in nephrology by potentially reducing the reliance on temporary catheters, which are associated with various complications. If successful, it may lead to new protocols that could reshape product development and market strategies in the dialysis sector.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor outcomes related to safety and efficacy of using existing access in CRRT, as well as any subsequent changes in clinical guidelines.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.